Search

everythinglearnresearchcommunity

for

Search:↓

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

Treating primary cicatricial alopecia is difficult and requires evidence-based methods.

Frontal fibrosing alopecia may run in families.

TCM is an effective and safe treatment for primary cicatricial alopecias.

Gabapentin helps with scalp itch, dutasteride works for frontal fibrosing alopecia, and more research is needed for better PCA treatments.

Certain genes and proteins may help diagnose and treat primary cicatricial alopecia.

Hair transplantation for Frontal Fibrosing Alopecia may work if the disease is inactive for 2 years and with ongoing treatment to maintain results.

Researchers found a white halo around hair in most patients with a specific type of hair loss, which helps in early diagnosis and treatment.

Horizontal sections of scalp biopsies are good for diagnosing Central Centrifugal Cicatricial Alopecia and help customize treatment.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

The report found a new type of hair loss in African-American women that affects more areas of the scalp than previously thought.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Primary cicatricial alopecia causes permanent hair loss by destroying hair follicles, and its exact cause is unknown.

Potential therapeutic targets for scarring hair loss are identified.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

The authors suggest a method for hair transplantation in fibrosing alopecia pattern distribution to improve treatment outcomes and cover bald areas.

Finasteride's effectiveness for frontal fibrosing alopecia is uncertain.

Using a special skin cream with gabapentin helped reduce symptoms of a certain scalp condition but didn't change nerve fibers or skin chemicals.

Fibrosing alopecia in a pattern distribution is a new type of scarring hair loss that resembles common baldness and an autoimmune skin disease.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.

Severe CCCA may be biologically and clinically different from milder forms.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.

Low-dose metformin may help hair regrowth and reduce inflammation in CCCA.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.